TYRA Tyra Biosciences, Inc.
Nasdaq · SEC CIK 1863127 · EDGAR
- Bought, last 12 months
- $20.0K 1 purchases by 1 insiders
- Sold, last 12 months
- $10.59M 8 sales by 3 insiders
- Filings on record
- 172 since 2021-09-17, latest 2026-09-17 19:29
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| MORE ROBERT J | Dir | — | $5.25M |
| Bensen Daniel | Chief Discovery Off | — | $4.81M |
| KAPLAN GILLA | Dir | — | $528.5K |
| Verjee Rehan | Dir | $20.0K | — |
| Rueb Yuliya | VP, Fin (PAO) | — | — |
| Warner Douglas J | Chief Medical Off | — | — |
| Ashar Bhavesh | COO | — | — |
| Harris Todd | Pres, CEO, Dir | — | — |
| Fuhrman Alan | CFO | — | — |
Transactions 129
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-10-14 | 2022-10-12 | TYRA | Patel Piyush R. | Chief Development Off | G - Gift | $0.00 | -56.3K | 82.2K | -41% | $0 | |
| 2022-09-19 | 2022-09-15 | TYRA | Hudkins Robert L. | CTO | A - Grant | $7.66 | +1,040 | 273.6K | +0.4% | +$7,966 | |
| 2022-09-19 | 2022-09-15 | TYRA | van den Boom Esther | CFO | A - Grant | $7.66 | +1,452 | 121.9K | +1% | +$11.1K | |
| 2022-09-19 | 2022-09-15 | TYRA | Patel Piyush R. | Chief Development Off | A - Grant | $7.66 | +1,040 | 138.5K | +0.8% | +$7,966 | |
| 2022-09-19 | 2022-09-15 | TYRA | Tada Hiroomi | Chief Medical Off | A - Grant | $7.66 | +612 | 81.2K | +0.8% | +$4,688 | |
| D | 2022-09-08 | 2022-03-15 | TYRA | Tada Hiroomi | Chief Medical Off | A - Grant | $8.53 | +2,703 | 80.6K | +3% | +$23.1K |
| D | 2022-09-08 | 2022-03-15 | TYRA | Patel Piyush R. | Chief Development Off | A - Grant | $8.53 | +2,408 | 137.5K | +2% | +$20.5K |
| D | 2022-09-08 | 2022-03-15 | TYRA | van den Boom Esther | CFO | A - Grant | $8.53 | +1,800 | 120.4K | +2% | +$15.4K |
| D | 2022-09-08 | 2022-03-15 | TYRA | Harris Todd | CEO, Dir | A - Grant | $8.53 | +3,125 | 1.70M | +0.2% | +$26.7K |
| D | 2022-09-08 | 2022-03-15 | TYRA | Swanson Ronald V. | CSO | A - Grant | $8.53 | +3,125 | 273.3K | +1% | +$26.7K |
| D | 2022-09-08 | 2022-03-15 | TYRA | Hudkins Robert L. | CTO | A - Grant | $8.53 | +2,408 | 272.5K | +0.9% | +$20.5K |
| 2021-12-21 | 2021-12-17 | TYRA | Boxer Asset Management Inc. | 10% | P - Purchase | $13.12 | +125.0K | 6.45M | +2% | +$1.64M | |
| DI | 2021-09-21 | 2021-09-17 | TYRA | Chen Bihua | Dir, Former 10% Owner | P - Purchase | $16.00 | +312.5K | 1.07M | +41% | +$5.00M |
| DI | 2021-09-21 | 2021-09-17 | TYRA | Chen Bihua | Dir, Former 10% Owner | C - Cnv Deriv | — | +757.4K | 757.4K | New | — |
| DM | 2021-09-20 | 2021-09-17 | TYRA | Canaan XI L.P. | 10% | C - Cnv Deriv | — | +4.41M | 473.4K | New | — |
| DMAI | 2021-09-20 | 2021-09-17 | TYRA | Kjellson Nina S | Dir | C - Cnv Deriv | — | +4.41M | 473.4K | New | — |
| DI | 2021-09-17 | 2021-09-17 | TYRA | MORE ROBERT J | Dir | P - Purchase | $16.00 | +156.2K | 4.08M | +4% | +$2.50M |
| DI | 2021-09-17 | 2021-09-17 | TYRA | MORE ROBERT J | Dir | C - Cnv Deriv | — | +3.81M | 3.92M | +3,375% | — |
| DMI | 2021-09-17 | 2021-09-17 | TYRA | RA Capital Nexus Fund, L.P. | Dir, 10% | C - Cnv Deriv | — | +5.99M | 4.05M | New | — |
| DI | 2021-09-17 | 2021-09-17 | TYRA | RA Capital Nexus Fund, L.P. | Dir, 10% | P - Purchase | $16.00 | +1.25M | 5.30M | +31% | +$20.00M |
| DI | 2021-09-17 | 2021-09-17 | TYRA | Hudson Peter A | 10% | P - Purchase | $16.00 | +156.2K | 4.08M | +4% | +$2.50M |
| DI | 2021-09-17 | 2021-09-17 | TYRA | Hudson Peter A | 10% | C - Cnv Deriv | — | +3.81M | 3.92M | +3,375% | — |
| D | 2021-09-17 | 2021-09-17 | TYRA | Harris Todd | CEO, Dir | C - Cnv Deriv | — | +34.0K | 1.70M | +2% | — |
| DMI | 2021-09-17 | 2021-09-17 | TYRA | Kjellson Nina S | Dir | C - Cnv Deriv | — | +4.41M | 473.4K | New | — |
| DI | 2021-09-17 | 2021-09-17 | TYRA | van den Boom Esther | CFO | C - Cnv Deriv | — | +21.3K | 21.3K | New | — |
| D | 2021-09-17 | 2021-09-17 | TYRA | Bensen Daniel | COO | C - Cnv Deriv | — | +8,501 | 528.0K | +2% | — |
| D | 2021-09-17 | 2021-09-17 | TYRA | CHEN ISAN | Dir | C - Cnv Deriv | — | +61.4K | 192.8K | +47% | — |
| DM | 2021-09-17 | 2021-09-17 | TYRA | Boxer Capital, LLC | 10% | C - Cnv Deriv | — | +5.99M | 288.1K | New | — |
| D | 2021-09-17 | 2021-09-17 | TYRA | Boxer Capital, LLC | 10% | P - Purchase | $16.00 | +625.0K | 6.32M | +11% | +$10.00M |
Purchase Sale Sale after option exercise All abbreviations